Context Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CNTX Key Statistics
Stock Snapshot
The current Context Therapeutics(CNTX) stock price is $2.92, with a market capitalization of 267.83M. The stock trades at a price-to-earnings (P/E) ratio of -10.43.
On 2026-03-10, Context Therapeutics(CNTX) stock traded between a low of $2.71 and a high of $3.03. Shares are currently priced at $2.92, which is +7.7% above the low and -3.6% below the high.
The Context Therapeutics(CNTX)'s current trading volume is 803.38K, compared to an average daily volume of 989.35K.
In the last year, Context Therapeutics(CNTX) shares hit a 52-week high of $3.30 and a 52-week low of $0.49.
In the last year, Context Therapeutics(CNTX) shares hit a 52-week high of $3.30 and a 52-week low of $0.49.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.